By Elissa Thorner, MHS Patient AdvocateCare+Wear Seven key things to know about breast cancer awareness for early detection are: It’s important to be aware of these risks and take steps to reduce them ...

Atossa Therapeutics has strong financials with $79.5 million in cash and a cash runway of 13-14 quarters, minimizing ...

Significant Ki-67 protein suppression in HR-positive, HER2-negative breast cancer was seen among patients treated with ...

H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Atossa Therapeutics (ATOS – Research Report) today and set a price target ...

Atossa Therapeutics (ATOS) released positive topline data from the KARISMA-Endoxifen Phase 2 study of z-endoxifen in premenopausal women with ...

Atossa and the Karolinska Institute expect to report detailed results from the KARISMA-Endoxifen trial at the San Antonio Breast Cancer Symposium in December, followed by full publication of the ...

Vasomotor symptoms (VMS) during the menopause transition (MT) are associated with an increased risk for type 2 diabetes (T2D) ...

Rheumatology Advisor interviewed Fiona Watt, PhD, to discuss the relationship between menopause and rheumatic disease.

There’s a popular belief that period cravings are linked to hormones. But researchers now think these cravings are culturally ...

“It’s very individualized treatment. It depends on your age, if you’re premenopausal or post-menopausal, and your receptor status, and your stage, and your HER2 receptor status. So, every patient ...

Medically reviewed by Adam M. Brufsky, MD, PhD The exact cause or causes of triple-negative breast cancer are unknown, but ...